Transcripto E2A-PBX1 en paciente pediátrico con leucemia aguda híbrida linfoide b/mieloide

Amor Vigil, Ana María; Fernández Martínez, Lesbia; Díaz Alonso, Carmen Alina; Ruiz Moleón, Vera; Lavaut Sánchez, Kalia; Marsán Suárez, Vianed; Machín García, Sergio; Garrote Santana, Heidys.
Rev. cuba. hematol. inmunol. hemoter ; 33(3): 95-101, jul.-set. 2017. ilus, tab
Artículo en Español | LILACS | ID: biblio-960425

Documentos relacionados

  1. Diagnostic workup of acute leukemias of ambiguous lineage.
  2. T/myeloid MPAL: origin and pathogenesis.
  3. Clinical Characteristics and Diagnosis of Ph-Positive Mixed Phenotype Acute Leukemia.
  4. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).
  5. The genetic basis and cell of origin of mixed phenotype acute leukaemia.
  6. Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
  7. Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy.
  8. Mixed phenotype acute leukemia: Biological profile, clinical characteristic and treatment outcomes: Report of the population-based study.
  9. Identification of a novel KMT2A/GIMAP8 gene fusion in a pediatric patient with acute undifferentiated leukemia.
  10. CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph<sup>+</sup> mixed phenotype acute leukaemia with minimal residual disease.